IDXX vs INVA · P/E 40, rev $2.36B vs P/E 3.6, rev $217.6M
IDEXX Laboratories Inc (IDXX) versus Innoviva Inc (INVA) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Innoviva Inc (INVA) is a biotechnology company listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported INVA revenue for 2026-06-30 was $217.6M. Net income was $103.2M. INVA currently screens at market cap $1.66B and trailing P/E 3.6.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. INVA currently screens at market cap $1.66B and trailing P/E 3.6.
Not investment advice. Open the IDXX and INVA stock pages for the full models.
Not investment advice.